Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Baxby, Derrick
1996.
The Jenner bicentenary; still uses for smallpox vaccine.
Epidemiology and Infection,
Vol. 116,
Issue. 3,
p.
231.
Baxby, Derrick
1996.
Two hundred years of vaccination.
Current Biology,
Vol. 6,
Issue. 7,
p.
769.
Boulanger, Denise
Green, Philip
Smith, Tim
Czerny, Claus-Peter
and
Skinner, Michael A.
1998.
The 131-Amino-Acid Repeat Region of the Essential 39-Kilodalton Core Protein of Fowlpox Virus FP9, Equivalent to Vaccinia Virus A4L Protein, Is Nonessential and Highly Immunogenic.
Journal of Virology,
Vol. 72,
Issue. 1,
p.
170.
Salmon-Ceron, Dominique
Excler, Jean-Louis
Finkielsztejn, Laurent
Autran, Brigitte
Gluckman, Jean-Claude
Sicard, Didier
Matthews, Thomas J.
Meignier, Bernard
Valentin, Christian
Habib, Raphaelle El
Blondeau, Christine
Raux, Maurice
Moog, Christiane
Tartaglia, James
Chong, Pele
Klein, Michel
Milcamps, Bruno
Heshmati, Farad
Plotkin, Stanley
Group, The Agis
and
Sida, L'Agence Nationale De Recherches Su
1999.
Safety and Immunogenicity of a Live Recombinant Canarypox Virus Expressing HIV Type 1 gp120 MN tm/gag/protease LAI (ALVAC-HIV, vCP205) Followed by a p24E-V3 MN Synthetic Peptide (CLTB-36) Administered in Healthy Volunteers at Low Risk for HIV Infection.
AIDS Research and Human Retroviruses,
Vol. 15,
Issue. 7,
p.
633.
Schultz, A. M.
1999.
Vaccines.
Vol. 133,
Issue. ,
p.
357.
Vaidya, Rajesh
López, Gabriel
and
López, José A.
2000.
Kirk-Othmer Encyclopedia of Chemical Technology.
Skinner, M. A.
Boulanger, D.
and
Smith, T.
2000.
Morphogenesis and release of fowlpox virus.
Journal of General Virology,
Vol. 81,
Issue. 3,
p.
675.
van Oirschot, J.T.
2001.
Vaccinology: Present and future of veterinary viral vaccinology: A review.
Veterinary Quarterly,
Vol. 23,
Issue. 3,
p.
100.
Kusters, I.
2001.
vaccins du futur : nouvelles technologies.
Journal de Pédiatrie et de Puériculture,
Vol. 14,
Issue. 6,
p.
370.
Vázquez‐Blomquist, Dania
González, Syduet
and
Duarte, Carlos A.
2002.
Effect of promoters on cellular immune response induced by recombinant fowlpox virus expressing multi‐epitope polypeptides from HIV‐1.
Biotechnology and Applied Biochemistry,
Vol. 36,
Issue. 3,
p.
171.
Boulanger, Denise
Green, Philip
Jones, Brenda
Henriquet, Gwenn
Hunt, Lawrence G.
Laidlaw, Stephen M.
Monaghan, Paul
and
Skinner, Michael A.
2002.
Identification and Characterization of Three Immunodominant Structural Proteins of Fowlpox Virus.
Journal of Virology,
Vol. 76,
Issue. 19,
p.
9844.
Maheshwari, Gargi
Jannat, Risat
McCormick, Lisa
and
Hsu, David
2004.
Thermal inactivation of adenovirus type 5.
Journal of Virological Methods,
Vol. 118,
Issue. 2,
p.
141.
Weli, Simon Chioma
Nilssen, Øivind
and
Traavik, Terje
2005.
Avipoxvirus multiplication in a mammalian cell line.
Virus Research,
Vol. 109,
Issue. 1,
p.
39.
Jannat, Risat
Hsu, David
and
Maheshwari, Gargi
2008.
Inactivation of Adenovirus Type 5 by Caustics.
Biotechnology Progress,
Vol. 21,
Issue. 2,
p.
446.
Patel, J.R.
and
Heldens, J.G.M.
2009.
Immunoprophylaxis against important virus diseases of horses, farm animals and birds.
Vaccine,
Vol. 27,
Issue. 12,
p.
1797.
Villarreal, Daniel O
Talbott, Kendra T
Choo, Daniel K
Shedlock, Devon J
and
Weiner, David B
2013.
Synthetic DNA vaccine strategies against persistent viral infections.
Expert Review of Vaccines,
Vol. 12,
Issue. 5,
p.
537.
Gorini, Giacomo
Fourati, Slim
Vaccari, Monica
Rahman, Mohammad Arif
Gordon, Shari N.
Brown, Dallas R.
Law, Lynn
Chang, Jean
Green, Richard
Barrenäs, Fredrik
Liyanage, Namal P. M.
Doster, Melvin N.
Schifanella, Luca
Bissa, Massimiliano
Silva de Castro, Isabela
Washington-Parks, Robyn
Galli, Veronica
Fuller, Deborah H.
Santra, Sampa
Agy, Michael
Pal, Ranajit
Palermo, Robert E.
Tomaras, Georgia D.
Shen, Xiaoying
LaBranche, Celia C.
Montefiori, David C.
Venzon, David J.
Trinh, Hung V.
Rao, Mangala
Gale, Michael
Sekaly, Rafick P.
Franchini, Genoveffa
and
Evans, David T.
2020.
Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition.
PLOS Pathogens,
Vol. 16,
Issue. 3,
p.
e1008377.
Kudlay, Dmitry
and
Svistunov, Andrey
2022.
COVID-19 Vaccines: An Overview of Different Platforms.
Bioengineering,
Vol. 9,
Issue. 2,
p.
72.